AbbVie Stock Jumped Today: Deal Sparks New Outlook for Investors
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Evaluate wide market index fund performance against the SP 500 in retirement planning, emphasizing return consistency and fee impact.
28,313 articlesAbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
When a prominent investor trims a large stake, the market often swings. This piece breaks down what happened with Aca...
In 2025, a surprising shift reshaped the starter-home landscape: flippers supplied more starter homes than traditiona...
In a market crowded with megacaps, an overlooked energy stock may offer outsized upside in 2026. Learn how to spot th...
A quiet stake in IonQ has sparked big questions. Is Amazon signaling a sweeping strategic shift in quantum computing,...
An $18 million wager on a rental business with decades of dividend growth sounds ambitious. This article breaks down ...
As Chewy released its latest earnings, investors faced mixed signals: growing revenue and better margins, but cautiou...
FedEx reports earnings Tuesday, and traders want a clear take on demand, costs, and guidance. This guide breaks down ...
Jim Cramer highlights Dollar General as a hedge fund favorite as energy costs rise, sending shoppers toward discount ...
As 2025 closes, star bulk (sblk) enters a new chapter. This guide breaks down the Q4 2025 results, fleet strategy, ba...
Biotech giants 2026 could offer a compelling mix of growth and stability for investors. This article dives into two p...